A detailed history of Fosun International LTD transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Fosun International LTD holds 12,314,248 shares of AMRX stock, worth $78.2 Million. This represents 54.23% of its overall portfolio holdings.

Number of Shares
12,314,248
Previous 21,521,301 42.78%
Holding current value
$78.2 Million
Previous $131 Million 42.88%
% of portfolio
54.23%
Previous 69.52%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$5.24 - $6.34 $48.2 Million - $58.4 Million
-9,207,053 Reduced 42.78%
12,314,248 $74.6 Million
Q3 2019

Nov 12, 2019

BUY
$2.29 - $7.1 $4.51 Million - $14 Million
1,969,300 Added 10.07%
21,521,301 $62.4 Million
Q3 2018

Nov 09, 2018

SELL
$16.4 - $24.27 $12.2 Million - $18 Million
-741,350 Reduced 3.65%
19,552,001 $434 Million
Q2 2018

Aug 13, 2018

BUY
$13.95 - $20.2 $283 Million - $410 Million
20,293,351 New
20,293,351 $333 Million

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $961M
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Fosun International LTD Portfolio

Follow Fosun International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.